The next step of neurogenesis in the context of Alzheimer’s disease

被引:0
|
作者
Hamid Reza Moradi
Vahid Hajali
Zabihollah Khaksar
Farzaneh Vafaee
Fatemeh Forouzanfar
Sajad Sahab Negah
机构
[1] Shiraz University,Department of Basic Sciences, School of Veterinary Medicine
[2] Mashhad University of Medical Sciences,Neuroscience Research Center
[3] Society for Brain Mapping and Therapeutics,Shefa Neuroscience Research Center
[4] Iranian Chapter,Department of Neuroscience, Faculty of Medicine
[5] SBMT,undefined
[6] Khatam Alanbia Hospital,undefined
[7] Mashhad University of Medical Sciences,undefined
来源
Molecular Biology Reports | 2021年 / 48卷
关键词
Neurogenesis; Alzheimer’s Disease; Pharmacology; Herbal Medicine; Cognitive Function;
D O I
暂无
中图分类号
学科分类号
摘要
Among different pathological mechanisms, neuronal loss and neurogenesis impairment in the hippocampus play important roles in cognitive decline in Alzheimer’s disease (AD). AD is a progressive and complex neurodegenerative diseases, which is very debilitating. The purpose of this paper is to review recent research into neurogenesis and AD and discuss how pharmacological drugs and herbal active components have impacts on neurogenesis and consequently improve cognitive functions. To date, despite huge research, no effective treatment has been approved for AD. Therefore, an avenue for future research and drug discovery is stimulating adult hippocampal neurogenesis (AHN). Evidence suggests that neurogenesis is regulated by the pharmacological treatment that may be recommended as a part of prophylaxis and therapeutic options for AD. However, the underlying mechanisms of regulating neurogenesis in AD are not well understood. To this point, we highlight to achieve an efficient treatment in AD by manipulating neurogenesis, it’s necessary to target all steps of neurogenesis.
引用
收藏
页码:5647 / 5660
页数:13
相关论文
共 50 条
  • [1] The next step of neurogenesis in the context of Alzheimer's disease
    Moradi, Hamid Reza
    Hajali, Vahid
    Khaksar, Zabihollah
    Vafaee, Farzaneh
    Forouzanfar, Fatemeh
    Negah, Sajad Sahab
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (07) : 5647 - 5660
  • [2] Combination Therapy for Alzheimer’s Disease — The Next Step
    Frank Jessen
    The Journal of Prevention of Alzheimer's Disease, 2019, 6 : 179 - 179
  • [3] Combination Therapy for Alzheimer's Disease - The Next Step
    Jessen, F.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2019, 6 (03): : 179 - 179
  • [4] Neurogenesis in Alzheimer's disease
    Rodriguez, Jose J.
    Verkhratsky, Alexei
    JOURNAL OF ANATOMY, 2011, 219 (01) : 78 - 89
  • [5] Neurogenesis and Alzheimer's Disease
    Taupin, Philippe
    DRUG TARGET INSIGHTS, 2006, 1 : 1 - 4
  • [6] Neurogenesis in Alzheimer's Disease Neocortex
    Marquez, Stefanie
    Zhou, Li
    Williams, Celia
    Miller, Carol
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2011, 70 (06): : 516 - 516
  • [7] Brain organoids: a next step for humanized Alzheimer's disease models?
    Gerakis, Yannis
    Hetz, Claudio
    MOLECULAR PSYCHIATRY, 2019, 24 (04) : 474 - 478
  • [8] Brain organoids: a next step for humanized Alzheimer’s disease models?
    Yannis Gerakis
    Claudio Hetz
    Molecular Psychiatry, 2019, 24 : 474 - 478
  • [9] Altered neurogenesis in Alzheimer's disease
    Ziabreva, Iryna
    Perry, Elaine
    Perry, Robert
    Minger, Stephen L.
    Ekonomou, Antigoni
    Przyborski, Stefan
    Ballard, Clive
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2006, 61 (03) : 311 - 316
  • [10] Alzheimer's disease, aneuploidy and neurogenesis
    Taupin, Philippe
    MEDICAL SCIENCE MONITOR, 2008, 14 (05): : LE6 - LE6